Hemolytic dynamics of weekly primaquine antirelapse therapy among Cambodians with acute Plasmodium vivax malaria with or without glucose-6-phosphate dehydrogenase deficiency
<br><strong>Background: </strong>Hemoglobin (Hb) data are limited in Southeast Asian glucose-6-phosphate dehydrogenase (G6PD) deficient (G6PD−) patients treated weekly with the World Health Organization–recommended primaquine regimen (ie, 0.75 mg/kg/week for 8 weeks [PQ 0.75]).<...
Main Authors: | Taylor, W, Kheng, S, Muth, S, Tor, P, Kim, S, Bjorge, S, Topps, N, Kosal, K, Sothea, K, Souy, P, Char, C, Vanna, C, Ly, P, Khieu, V, Christophel, E, Kerleguer, A, Pantaleo, A, Mukaka, M, Menard, D, Baird, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2019
|
Similar Items
-
Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria
by: Taylor, WRJ, et al.
Published: (2021) -
The ethics of using a placebo arm in randomized controlled trials: a case of in a primaquine antirelapse study
by: Cheah, P, et al.
Published: (2017) -
The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians
by: Dysoley, L, et al.
Published: (2019) -
An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia
by: Leang, R, et al.
Published: (2016) -
Modelling primaquine-induced haemolysis in G6PD deficiency
by: White, N, et al.
Published: (2017)